Author

Yali Zhong

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world pharmacovigilance analysis and cross-database consistency assessment of resmetirom-related adverse events using FAERS and VigiAccess

Objective This study aimed to characterize the post-marketing safety profile and potential adverse event signals of resmetirom using the FAERS and VigiAccess databases. Methods FAERS reports from the quarter of initial United States approval through 2026Q1 were analyzed. After deduplication, DEMO, DRUG, REAC, THER, and...

Ya-Li Zhong, Cong Hou, Ling-Zuo Zhao et al. · Frontiers in Pharmacology · 0 citations

Open access Aug 2026

Real-world pharmacovigilance assessment of meropenem-associated adverse events: age stratification and time-to-onset analysis using FAERS

Background Meropenem is a broad-spectrum carbapenem antibiotic widely used for severe infections; however, its real-world adverse event profile and age-stratified pharmacovigilance signals remain insufficiently characterized. This study aimed to evaluate signals of meropenem-associated adverse events using the FDA Adve...

Xiaobin Luo, Yali Zhong, Yong Zou et al. · Frontiers in Medicine · 0 citations